News
As the FDA halts the sale of Ozempic and Zepbound copycats, online clinics have begun offering liraglutide, an older GLP-1 ...
In the first head-to-head trial of its kind, people with obesity who took tirzepatide (sold under the brand names Mounjaro ...
Talking to reporters on Monday, May 12, Donald Trump said that a “neurotic” and rich friend got their “fat shot” at a ...
WGN’s Dina Bair has the latest on new medical information, including: Study: Mounjaro helped people achieve more weight loss ...
Eventually, it was proven that Mounjaro is more affective than Wegovy in terms of weight loss, with 32 per cent of ...
5d
Us Weekly on MSNThe federal ban on generic GLP-1 starts this month. Here's what you can doIf you're following the GLP-1 (Ozempic and other prescription weight-loss medications) scene, you may have read that the FDA ...
Hims & Hers Health, Inc.'s Q1 results show 111% growth, yet shares fell 8%. Click for a look at the impact of drug access, ...
Fashion and beauty’s new appetite for collaborating with food brands collides with a worrying return to ’90s-era thinness and ...
Metamorphx is emerging as a leading natural GLP-1 alternative for weight loss in 2025. With prescription options like ...
Sometimes, it makes sense to skip insurance and instead take advantage of a health savings account or flexible savings ...
With Wegovy in its portfolio, Novo Nordisk is a very good bet to continue being a winner. As it's currently considered something of an underdog, with its stock priced accordingly, it's also trading at ...
The pharmaceutical firm Novo Nordisk is pursuing a multipronged strategy to regain market share that it has lost to Eli Lilly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results